NCT05232032 Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation Status RECRUITING Phase PHASE2
NCT05215327 High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients Status RECRUITING Phase PHASE2
NCT05195918 Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients Status COMPLETED Phase PHASE1
NCT05194085 Impact of Male Provider Phone Calls to Increase Men's Clinic Linkage After HIVST Status UNKNOWN Phase NA
NCT05191797 Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT05187897 CHV-NEO: Community-based Digital Communication to Support Neonatal Health Status RECRUITING Phase NA
NCT05183828 Effect of HSD3B1 (1245C) Gene Mutation on Treatment of Stage I-III Breast Cancer Status RECRUITING Phase PHASE4
NCT05169658 Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma Status COMPLETED Phase PHASE2
NCT05161533 Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial Status WITHDRAWN Phase PHASE2